42,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
21 °P sammeln
  • Broschiertes Buch

U.S. assets and citizens remain the number one target of international terrorism. The events of September 11th clearly show the dimensions such attacks can reach. This volume catalyzes the thinking of the medical community and informs those who will rely on it capabilities in these uncertain times. Terrorism and Medical Responses: U.S. Lessons and Policy Implications is an initiative undertaken by the International Center for Terrorism Studies (ICTS) and the National Security Health Policy Center (NSHPC), both at the Potomac Institute for Policy Studies, and aims at improving medical response…mehr

Produktbeschreibung
U.S. assets and citizens remain the number one target of international terrorism. The events of September 11th clearly show the dimensions such attacks can reach. This volume catalyzes the thinking of the medical community and informs those who will rely on it capabilities in these uncertain times. Terrorism and Medical Responses: U.S. Lessons and Policy Implications is an initiative undertaken by the International Center for Terrorism Studies (ICTS) and the National Security Health Policy Center (NSHPC), both at the Potomac Institute for Policy Studies, and aims at improving medical response in this important area of public concern. Published under the Transnational Publishers imprint.
Autorenporträt
Prof. Yonah Alexander is Senior Fellow and Director, International Center for Terrorism Studies, Potomac Institute for Policy Studies, as well as Director, Inter-University Center for Terrorism Studies and Co-Director, Inter-University Center for Legal Studies. He has published over 70 books in the field of terrorism and international affairs and is founding editor of Terrorism: An International Journal. Dr. Stephen D. Prior is Research Director, National Security Health Policy Center, Potomac Institute. He is an acknowledged leader in the field of medical defense against the threat posed by biological weapons (BW) who, since 1986, has advised and worked closely with government and commercial defense staffs, world-wide, to develop integrated strategies of medical countermeasures for BW defense.